Optibrium releases powerful metabolism prediction capability in next generation StarDrop software
Cambridge, UK – Optibrium, a leading developer of software and AI solutions for drug discovery, launches the latest version of its drug discovery platform, StarDrop 7.5, introducing a powerful module for drug metabolism prediction.
Get to know the inflammatory bowel disease (IBD) team at the NIHR BioResource
Who are they, what a day looks like in the team and everything involved in making our Inflammatory Bowel Disease (IBD) team one of the core cogs in the workings of the NIHR BioResource!
Ion channel drug developer Maxion Therapeutics appoints Eva-Lotta Allan as Chair of its Board of Directors
Maxion Therapeutics (“Maxion”), the biotechnology company developing antibody-based drugs for previously untreatable ion channel- and GPCR-driven diseases, announced the appointment of senior industry leader Eva-Lotta Allan as the Chair of its Board of Directors. The announcement comes at an important moment of growth by the company as it advances its lead programme towards the clinic, following…
Reflecting on our campaign to increase volunteer diversity
NIHR BioResource for Translational Research writes...As our 12-week campaign with Egality Health and eight community-based health advocacy organisations has come to a close, we’re reflecting on our successes and sharing some key learnings going forward. We also heard from some of our community organisation leaders on their thoughts on the campaign and the future of health research.
Optical Genome Mapping shines light on complex structural variants in Genome
Unlock a 25% discount today on all OGM services with Source Genomics, limited time only.
SPT Labtech Empowers UK Genomics Community by Opening its Doors for the firefly® Roadshow
Cambridge, UK, 19 September 2023 – SPT Labtech, a global leader in the design and development of automated instrumentation and consumables for life science applications, will host the UK leg of the firefly®
Takeda and Sanofi join Milner Therapeutics Consortium
The Milner Therapeutics Institute are excited to announce that two new pharma partners — Takeda and Sanofi — have joined the Milner Consortium in the past month.
Astrea Bioseparations expands manufacturing and warehousing capacity to support growing demand for its chromatography solutions in North America
Cambridge, UK - Astrea Bioseparations, a leading provider of high-quality bioseparation and purification technologies that help to improve patient outcomes with safer and more effective production of therapeutics, announces the expansion of its manufacturing and warehousing capabilities in the US. The increased capacity reflects growing demand for the Company’s chromatography solutions in North…
No boundaries: Guardtech Group opening up new horizons with CleanCube
Suffolk-based cleanroom construction experts now providing ‘large-scale portable facilities’ at home and abroad.
Event Production at King’s College Hall Cambridge
When it comes to hosting and capturing memorable events, few places are as iconic as King’s College in Cambridge. Renowned for its rich history and exquisite architecture, this prestigious venue has witnessed countless memorable events over the years.
Black Internship Programme 2023
For the third year running, the NIHR BioResource is delighted to welcome two interns to work with us as we continue our support for the Health Data Science Black Internship Programme. This initiative helps provide opportunities for talented early-career Black people in the UK to flourish in their future health data science careers.
Broken String Biosciences closes $15M Series A funding round
Cambridge, UK - Broken String Biosciences (“Broken String”), a genomics company building a technology platform to drive the development of cell and gene therapies that are safer by design, today announced that it has closed a $15 million Series A investment round, co-led by Illumina Ventures and Mérieux Equity Partners, with contributions from HERAN Partners, and existing investors Tencent and…
Team EBCam take part in the London Landmarks Skyscraper Challenge
Congratulations to the team of four from EBCam Ltd who took part in a world first event, the London Landmark’s Skyscraper Challenge, to raise money for Tommy’s charity. They completed a 'tower run' up 42 floors of 'The Cheesegrater' followed by a jaw dropping 200 meter abseil down the building.
Studies reveal ADHD medication improves quality of life for child survivors of brain tumours
A repurposed ADHD medication could change the lives of children who have survived a brain tumour, after new UK studies reveal improvements in brain functioning and improved quality of life for patients.
ELRIG UK establishes Engagement Strategy Work Group
Cambridge, UK, 14 September 2023: The European Laboratory Research & Innovation Group (ELRIG) UK announces the formation of its Engagement Strategy Work Group (ESWG).
AI and women’s health: the curious case of the missing data
AI technologies help to improve diagnosis and treatment in women’s health in a number of ways, from identifying whether cervical cancer is present in cell images of Pap smear slides, to predicting ovulation based on temperature data.
Inflation Reduction Act: Adjustments to medication pricing and reimbursement
This is part two of a three-part series published in Managed Healthcare Executive.
Apple leaves door open for android to lead the way on innovation
electronRx writes...Apple announced the launch of the iPhone 15 on 12th September to worldwide fanfare. The manufacturer hailed the new mobile phone as a ‘huge leap forward’ for the brand, with new attractive design features, including colour, contoured edges, and colour-infused black glass.
Inflation Reduction Act: Increasing healthcare coverage, reducing healthcare prices. How will it impact manufacturers?
This is part 1 of a three-part series published in Managed Healthcare Executive.
John Hicks Co Ltd announces a new provision for clients in the centre of Cambridge.
John Hicks Co Ltd is now offering face to face consultations to clients within the heart of Cambridge.
Guardtech Group gearing up for busy Autumn exhibition schedule
Haverhill-based cleanroom construction specialists set to cover wide range of industries with stellar show line-up
Kuano raises £1.8M in seed funding to accelerate quantum drug discovery
Cambridge, UK, 12 September 2023: Kuano, a drug discovery company combining quantum mechanics with AI to design the next generation of medicines, announces the close of its £1.8M seed funding round, led by Mercia Ventures, and including ACF Investors, Ascension Ventures, o2h Ventures, Meltwind Advisory LLP, and other Angel investors. The investment will facilitate further validation of Kuano’s…